I haven't seen a reference to it on this site. Does anyone know if this has been discussed?
When I fist came across this, I was very excited, thought about exploring a 'buy group' like what was done with Nilotinib, but then because I have PD, I forgot to pursue it (ha,) but was reviewing bookmarks today and rediscovered it.
1 dose reduced a-synucleai 97% in 1 hour!!
"... mean reduction of free serum alpha-synuclein levels of up to 97 percent after a single dose, which were statistically significant (p < 0.0001), and confirmed after two additional monthly doses."
"Prothena's phase 1b multiple ascending dose study represents the first report of an antibody targeting alpha-synuclein in patients with Parkinson's disease and showed that PRX002—also known as RG7935—was able to reduce serum levels of the protein by up to 97% with a single dose."
What am I missing?